<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> is a serious complication in transfusion-dependent patients </plain></SENT>
<SENT sid="1" pm="."><plain>Few studies have addressed this issue in Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a retrospective analysis of <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, and its related complications in 31 transfusion-dependent Italian <z:chebi fb="28" ids="35299">DBA</z:chebi> patients whose records included one or more evaluation of liver iron concentration (LIC) by means of noninvasive magnetic liver susceptometry with a superconductive quantum interference device (SQUID) </plain></SENT>
<SENT sid="3" pm="."><plain>This cohort is also matched with a group of transfusion-dependent <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia major</z:e> patients to look for differences </plain></SENT>
<SENT sid="4" pm="."><plain>A severe <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> was observed in 54% patients, especially among those inadequately chelated </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="28" ids="35299">DBA</z:chebi> patients displayed a significantly higher LIC than the regularly chelated beta-thalassemics </plain></SENT>
<SENT sid="6" pm="."><plain>This difference may have been attributable to nonoptimal chelation (<z:hpo ids='HP_0003584'>late onset</z:hpo>, type, dose, prescription, and compliance), or an unknown biological mechanism that lead to an early severe <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We therefore suggest that <z:hpo ids='HP_0000001'>all</z:hpo> transfusion patients should have an accurate record of their iron intake, a regular monitoring of <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, in order to start chelation when a critical transfusion load is reached, and to test the efficacy/compliance of chelation treatment </plain></SENT>
<SENT sid="8" pm="."><plain>Physicians taking care of transfusion-dependent <z:chebi fb="28" ids="35299">DBA</z:chebi> patients must be concerned about the frequent and early complications such as cardiac toxicity </plain></SENT>
<SENT sid="9" pm="."><plain>Am </plain></SENT>
<SENT sid="10" pm="."><plain>J </plain></SENT>
<SENT sid="11" pm="."><plain>Hematol., 2009 </plain></SENT>
<SENT sid="12" pm="."><plain>(c) 2009 Wiley-Liss, Inc </plain></SENT>
</text></document>